Mairene Coto‐Llerena

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis

Ruize Gao, Ravi Kiran Reddy Kalathur, Mairene Coto‐Llerena et al. · EMBO Molecular Medicine · 2021 · 493 citations · Full text

Medicine, Cancer Biology, Oncology +12

Arginine reprograms metabolism in liver cancer via RBM39

Dirk Mossmann, Christoph Müller, Sujin Park et al. · Cell · 2023 · 277 citations · Full text

Medicine, Cancer Biology, Oncology +17

High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes

Mairene Coto‐Llerena, Caner Ercan, Venkatesh Kancherla et al. · Frontiers in Oncology · 2020 · 97 citations · Full text

Medicine, Molecular Biology, Oncology +17

Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study

Charlotte K.Y. Ng, G.G. Di Costanzo, Nadia Tosti et al. · Annals of Oncology · 2018 · 91 citations · Full text

Medicine, Genetics, Oncology +16

Donor and Recipient IL28B Polymorphisms in HCV-Infected Patients Undergoing Antiviral Therapy before and after Liver Transplantation

Mairene Coto‐Llerena, Sofía Pérez‐del‐Pulgar, Gonzalo Crespo et al. · American Journal of Transplantation · 2011 · 85 citations

Life Sciences, Immunology, Infectious Diseases +16